Table 5.
Multivariate Cox Regression Analysis for Association of Overall Survival With Patient Characteristics (n = 61)
| Variable | Hazards Ratio |
95% CI | P |
|---|---|---|---|
| Time to AML (on log scale)a | 1.42 | 1.02–1.96 | .037 |
| MDS/MPN treatment HMA/L vs other | 3.05 | 1.62–5.71 | .0005 |
| Cytogenetics, intermediate vs poor | 0.46 | 0.25–0.87 | .017 |
CI, confidence interval; AML, acute myeloid leukemia; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasm; HMA/L, hypomethylating agent (ie, decitabine and azacitidine)/lenalidomide.
a
One log unit = 2.7 months.